| Human african trypanosomiasis R Brun, J Blum, F Chappuis, C Burri The Lancet 375 (9709), 148-159, 2010 | 1110 | 2010 |
| Treatment of human African trypanosomiasis—present situation and needs for research and development D Legros, G Ollivier, M Gastellu-Etchegorry, C Paquet, C Burri, J Jannin, ... The Lancet infectious diseases 2 (7), 437-440, 2002 | 388 | 2002 |
| Eflornithine for the treatment of human African trypanosomiasis C Burri, R Brun Parasitology research 90 (1), S49-S52, 2003 | 282 | 2003 |
| The phenomenon of treatment failures in Human African Trypanosomiasis R Brun, R Schumacher, C Schmid, C Kunz, C Burri Tropical Medicine & International Health 6 (11), 906-914, 2001 | 262 | 2001 |
| Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial C Burri, S Nkunku, A Merolle, T Smith, J Blum, R Brun The Lancet 355 (9213), 1419-1425, 2000 | 240 | 2000 |
| Clinical aspects of 2541 patients with second stage human African trypanosomiasis J Blum, C Schmid, C Burri Acta tropica 97 (1), 55-64, 2006 | 205 | 2006 |
| Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis J Blum, S Nkunku, C Burri Tropical Medicine & International Health 6 (5), 390-400, 2001 | 169 | 2001 |
| Chemotherapy against human African trypanosomiasis: is there a road to success? C Burri Parasitology 137 (14), 1987-1994, 2010 | 156 | 2010 |
| Diamidines for human African trypanosomiasis WD Wilson, HP De Koningº, CA Olson, G Pohlig Current opinion in investigational drugs 11 (8), 876-883, 2010 | 149 | 2010 |
| Antiparasitic activity of diallyl trisulfide (Dasuansu) on human and animal pathogenic protozoa (Trypanosoma sp., Entamoeba histolytica and Giardia lamblia) in vitro. ZR Lun, C Burri, M Menzinger, R Kaminsky Annales de la Societe Belge de Medecine Tropicale 74 (1), 51-59, 1994 | 138 | 1994 |
| New drugs for the treatment of human African trypanosomiasis: research and development J Keiser, C Burri, A Stich Trends in parasitology 17 (1), 42-49, 2001 | 120 | 2001 |
| Effectiveness of a 10-Day Melarsoprol Schedule for the Treatment of Late-Stage Human African Trypanosomiasis: Confirmation from a Multinational Study C Schmid, M Richer, CMM Bilenge, T Josenando, F Chappuis, ... Journal of Infectious Diseases 191 (11), 1922-1931, 2005 | 119 | 2005 |
| Human African Trypanosomiasis C Burri, F Chappuis, R Brun Manson's Tropical Diseases 23rd Edition, 606-621, 2013 | 116 | 2013 |
| Prevention‒a cost-effective way to fight the non-communicable disease epidemic N Probst-Hensch, M Tanner, C Kessler, C Burri, N Kuenzli Swiss Med Wkly 141, w13266, 2011 | 116 | 2011 |
| New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story EA Dickie, F Giordani, MK Gould, P Mäser, C Burri, JC Mottram, SPS Rao, ... Tropical Medicine and Infectious Disease 5 (1), 29, 2020 | 104 | 2020 |
| Pharmacokinetic properties of the trypanocidal drug melarsoprol C Burri, T Baltz, C Giroud, F Doua, HA Welker, K Brun Chemotherapy 39 (4), 225-234, 1993 | 93 | 1993 |
| Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment C Burri, J Keiser Tropical Medicine & International Health 6 (5), 412-420, 2001 | 91 | 2001 |
| Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness C Schmid, S Nkunku, A Merolle, P Vounatsou, C Burri The Lancet 364 (9436), 789-790, 2004 | 86 | 2004 |
| Cardiac involvement in African and American trypanosomiasis JA Blum, MJ Zellweger, C Burri, C Hatz The Lancet infectious diseases 8 (10), 631-641, 2008 | 85 | 2008 |
| An unusual type IB topoisomerase from African trypanosomes AL Bodley, AK Chakraborty, S Xie, C Burri, TA Shapiro Proceedings of the National Academy of Sciences 100 (13), 7539-7544, 2003 | 76 | 2003 |
